Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Susan Stanley, MD, PhD
Principal Scientist
Merck & Co Inc
Poster(s):
117: Analyzing Drug-Drug Interaction Risk Assessment Strategies for Protein Therapeutics in Inflammatory Bowel Disease: A Literature-Based Evidence Review
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
